Extracellular Matrix-Coated Composite Scaffolds Promote Mesenchymal Stem Cell Persistence and Osteogenesis

Biomacromolecules. 2016 Nov 14;17(11):3524-3531. doi: 10.1021/acs.biomac.6b01005. Epub 2016 Oct 26.

Abstract

Composite scaffolds of bioactive glass and poly(lactide-co-glycolide) provide advantages over homogeneous scaffolds, yet their therapeutic potential can be improved by strategies that promote adhesion and present instructive cues to associated cells. Mesenchymal stem cell (MSC)-secreted extracellular matrix (ECM) enhances survival and function of associated cells. To synergize the benefits of an instructive ECM with composite scaffolds, we tested the capacity of ECM-coated composite scaffolds to promote cell persistence and resultant osteogenesis. Human MSCs cultured on ECM-coated scaffolds exhibited increased metabolic activity and decreased apoptosis compared to uncoated scaffolds. Additionally, MSCs on ECM-coated substrates in short-term culture secreted more proangiogenic factors while maintaining markers of osteogenic differentiation. Upon implantation, we detected improved survival of MSCs on ECM-coated scaffolds over 3 weeks. Histological evaluation revealed enhanced cellularization and osteogenic differentiation in ECM-coated scaffolds compared to controls. These findings demonstrate the promise of blending synthetic and natural ECMs and their potential in tissue regeneration.

MeSH terms

  • Biocompatible Materials
  • Cell Differentiation / drug effects*
  • Cells, Cultured
  • Extracellular Matrix / drug effects
  • Humans
  • Mesenchymal Stem Cells / drug effects*
  • Osteogenesis / drug effects*
  • Polyglactin 910 / administration & dosage
  • Polyglactin 910 / chemistry
  • Regeneration / drug effects
  • Tissue Scaffolds / chemistry

Substances

  • Biocompatible Materials
  • Polyglactin 910